Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer
Clinical trial NCT01073865 · COMPLETED
Trial details
- NCT number
- NCT01073865
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-26
- Primary completion
- 2012-09-19
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.